Cargando…
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells
BACKGROUND: Nitric oxide (NO) and its oxidative reaction products have been repeatedly shown to block steroid receptor function via nitrosation of zinc finger structures in the DNA-binding domain (DBD). In consequence NO-donors could be of special interest for the treatment of deregulated androgen r...
Autores principales: | Laschak, Martin, Spindler, Klaus-Dieter, Schrader, Andres J, Hessenauer, Andrea, Streicher, Wolfgang, Schrader, Mark, Cronauer, Marcus V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376035/ https://www.ncbi.nlm.nih.gov/pubmed/22462810 http://dx.doi.org/10.1186/1471-2407-12-130 |
Ejemplares similares
-
Role of human glutathione transferases in biotransformation of the nitric oxide prodrug JS-K
por: Sjödin, Birgitta, et al.
Publicado: (2021) -
Glutathione Transferase (GST)-Activated Prodrugs
por: Ruzza, Paolo, et al.
Publicado: (2013) -
Glutathione and glutathione S-transferases in Barrett's epithelium.
por: Peters, W. H., et al.
Publicado: (1993) -
Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells
por: Zengerling, Friedemann, et al.
Publicado: (2012) -
Plant glutathione transferases
por: Dixon, David P, et al.
Publicado: (2002)